The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones
Abstract
Men have a higher incidence of hepatocellular carcinoma (HCC) than women. Epidemiologic and animal studies have suggested that it might be due to the stimulatory effects of androgen and the protective effects of estrogen. Recently, increasing molecular mechanisms underlying the carcinogenic effect of both sex hormones were reported. Knockout of androgen receptor (AR) expression in hepatocytes delayed the development of N′,N′-diethylnitrosamine (DEN)-induced HCC, suggesting the active AR pathway in augmenting the HCC risk. Moreover, an intriguing interaction between the viral protein of hepatitis B virus X protein (HBx) and the androgen pathway was established. HBx can enhance the transcriptional activity of AR in a ligand concentration-dependent manner, mainly through its effects on the c-Src and GSK-3β kinase pathways. The studies from the DEN-induced HCC mouse model further provided a mechanism for the protective role of estrogen in female HCC. Estrogen can protect hepatocytes from malignant transformation via downregulation of IL-6 release from Kupffer cells, a critical process in this mouse model. Intriguingly, suppression of the ERα protein by overexpression of miR-18a, which occurs preferentially in female HCC, was identified as a novel mechanism to block the tumor-protective function of estrogen in female HCC. In conclusion, the current studies demonstrated that the gender disparity of HCC is attributed by both androgen and estrogen sex hormone pathways, with distinct roles in each gender. Therefore, the ligand and the receptor factors of both sex hormones need to be included for assessing the relative risk of HCC patients of each gender.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Estimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Molecular mechanisms of alcohol-mediated carcinogenesis
Seitz, H. K., & Stickel, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2191 · Cited by 1,138
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,004
Liver: An organ with predominant innate immunity
Gao, B., Jeong, W.-I., & Tian, Z. (2008) · Hepatology · doi:10.1002/hep.22034 · Cited by 952
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Global control of hepatitis B virus infection
Kao, J.-H., & Chen, D.-S. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00315-8 · Cited by 805
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Villanueva, A., Chiang, D. Y., Newell, P., Peix, J., Thung, S., Alsinet, C., Tovar, V., Roayaie, S., Minguez, B., Sole, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.008 · Cited by 733
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J., Factor, V. M., & Thorgeirsson, S. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.006 · Cited by 710
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
Gomaa, A. I., Khan, S. A., Toledano, M. B., Waked, I., & Taylor-Robinson, S. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4300 · Cited by 700
Molecular mechanisms of hepatocellular carcinoma
Aravalli, R. N., Steer, C. J., & Cressman, E. N. K. (2008) · Hepatology · doi:10.1002/hep.22580 · Cited by 625
POSSIBLE ASSOCIATION BETWEEN BENIGN HEPATOMAS AND ORAL CONTRACEPTIVES
BAUM, J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92594-4 · Cited by 611
Genomics and Signaling Pathways in Hepatocellular Carcinoma
Villanueva, A., Newell, P., Chiang, D., Friedman, S., & Llovet, J. (2007) · Seminars in Liver Disease · doi:10.1055/s-2006-960171 · Cited by 556
Sakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.016 · Cited by 487 · cited 1×
“with the evidence mainly derived from the DEN-induced mouse HCC model. In this model, IL-1α released from DEN-damaged necrotic hepatocytes can initiate the induction and release of IL-6 from Kupffer cells, mainly through activation of the NF-κB pathway [”
Soy, isoflavones, and breast cancer risk in Japan
Yamamoto, S., Sobue, T., Kobayashi, M., Sasaki, S., & Tsugane, S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.906 · Cited by 391
Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
Simonetti, R. G., Liberati, A., Angiolini, C., & Pagliaro, L. (1997) · Annals of Oncology · doi:10.1023/a:1008285123736 · Cited by 380
Shiratori, Y., Shiina, S., Imamura, M., Kato, N., Kanai, F., Okudaira, T., Teratani, T., Tohgo, G., Toda, N., Ohashi, M., et al. (1995) · Hepatology · doi:10.1002/hep.1840220403 · Cited by 365
Trends in primary liver cancer
Deuffic, S., Poynard, T., Buffat, L., & Valleron, A.-J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78179-4 · Cited by 316
NF-κB signaling, liver disease and hepatoprotective agents
Sun, B., & Karin, M. (2008) · Oncogene · doi:10.1038/onc.2008.300 · Cited by 307
Liu, W., Yeh, S., Lu, C., Yu, S., Chen, H., Lin, C., Chen, D., & Chen, P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.029 · Cited by 255
Self-citationMa, W., Hsu, C., Wu, M., Wu, C., Wu, C., Lai, J., Jou, Y., Chen, C., Yeh, S., & Chang, C. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.046 · Cited by 252
Self-citationDNA Methylation and Environmental Exposures in Human Hepatocellular Carcinoma
Shen, L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.10.755 · Cited by 249
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis†
Maher, J. J., Leon, P., & Ryan, J. C. (2008) · Hepatology · doi:10.1002/hep.22399 · Cited by 203
Alward, W. L. M., McMahon, B. J., Hall, D. B., Heyward, W. L., Francis, D. P., & Bender, T. R. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.4.604 · Cited by 194
Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk
Yu, M.-W., Chang, H.-C., Chang, S.-C., Liaw, Y.-F., Lin, S.-M., Liu, C.-J., Lee, S.-D., Lin, C.-L., Chen, P.-J., Lin, S.-C., et al. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.041 · Cited by 189
Self-citationLee, C.-M., Lu, S.-N., Changchien, C.-S., Yeh, C.-T., Hsu, T.-T., Tang, J.-H., Wang, J.-H., Lin, D.-Y., Chen, C.-L., & Chen, W.-J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991001)86:7<1143::aid-cncr7>3.0.co;2-z · Cited by 186
Yu, M.-W., Yang, Y.-C., Yang, S.-Y., Cheng, S.-W., Liaw, Y.-F., Lin, S.-M., & Chen, C.-J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1644 · Cited by 183
Maria, N. D., Manno, M., & Villa, E. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00096-5 · Cited by 179
Chu, C., & Liaw, Y. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.039 · Cited by 174
Mathurin, Rixe, Carbonell, Bernard, Cluzel, Bellin, Khayat, Opolon, & Poynard (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00286.x · Cited by 164
Tai, D., Lin, S., Sheen, I., Chu, C., Lin, D., & Liaw, Y. (2009) · Hepatology · doi:10.1002/hep.22878 · Cited by 164
Iwasaki, M., Inoue, M., Otani, T., Sasazuki, S., Kurahashi, N., Miura, T., Yamamoto, S., & Tsugane, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9964 · Cited by 161
Yu, M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2023 · Cited by 148
Nakatani, T., Roy, G., Fujimoto, N., Asahara, T., & Ito, A. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01089.x · Cited by 147
Chiu, C.-M., Yeh, S., Chen, P., Kuo, T.-J., Chang, C.-J., Chen, P., Yang, W., & Chen, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609498104 · Cited by 135
Self-citationINK4a-ARF alterations and p53 mutations in hepatocellular carcinomas
Tannapfel, A., Busse, C., Weinans, L., Benicke, M., Katalinic, A., Geißler, F., Hauss, J., & Wittekind, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204902 · Cited by 129
Rachoń, D., Myśliwska, J. M., Suchecka-Rachoń, K., Więckiewicz, J., & Myśliwski, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720387 · Cited by 117
Viral hepatocarcinogenesis: from infection to cancer
Tan, A., Yeh, S., Liu, C., Cheung, C., & Chen, P. (2008) · Liver International · doi:10.1111/j.1478-3231.2007.01652.x · Cited by 114
Self-citationYang, W.-J., Chang, C.-J., Yeh, S., Lin, W.-H., Wang, S.-H., Tsai, T., Chen, D., & Chen, P. (2009) · Hepatology · doi:10.1002/hep.22833 · Cited by 110
Self-citationZacharakis, G., Koskinas, J. S., Kotsiou, S., Papoutselis, M. K., Tzara, F., Vafeiadis, N., Archimandritis, A. J., & Papoutselis, K. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20434 · Cited by 107
Protection of estrogens against the progression of chronic liver disease
Shimizu, I., & Ito, S. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00032.x · Cited by 105
Su, W.-H., Chao, C.-C., Yeh, S.-H., Chen, D., Chen, P., & Jou, Y. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl845 · Cited by 94
Self-citationIavarone, M. A., Lampertico, P., Seletti, C., Donato, M. F., Ronchi, G., Ninno, E. D., & Colombo, M. (2003) · Cancer · doi:10.1002/cncr.11528 · Cited by 79
Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats
Shimizu, I., Yasuda, M., Mizobuchi, Y., Ma, Y.-R., Liu, F., Shiba, M., HORIE, T., & Ito, S. (1998) · Gut · doi:10.1136/gut.42.1.112 · Cited by 79
Su, F., Chen, J., Cheng, S., Lin, C., Liu, Y., & Chu, F. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20771 · Cited by 69
Hormonal contraception and chemoprevention of female cancers.
Pike, M. C., & SPICER, D. V. (2000) · Endocrine Related Cancer · doi:10.1677/erc.0.0070073 · Cited by 61
Is human hepatocellular carcinoma a hormone-responsive tumor?
Maïo, M. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1682 · Cited by 53
Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease
Villa, E., Dugani, A., Moles, A., et al. (1998) · Hepatology · doi:10.1002/hep.510270413 · Cited by 53
Use of tamoxifen in advanced‐stage hepatocellular carcinoma
Nowak, A. K., Stockler, M. R., Chow, P. K. H., & Findlay, M. P. N. (2005) · Cancer · doi:10.1002/cncr.20963 · Cited by 52
Kurahashi, N., Inoue, M., Iwasaki, M., Tanaka, Y., Mizokami, M., Tsugane, S., & for the JPHC Study Group (2008) · International Journal of Cancer · doi:10.1002/ijc.24121 · Cited by 49
Ng, I. O., Ng, M., & Fan, S. T. (1997) · PubMed · Cited by 47
The Expression of Estrogen Receptors in Hepatocellular Carcinoma in Korean Patients
Wang, A. G., Lee, K., Kim, S. Y., Choi, J. Y., Lee, K. H., Kim, W., Wang, H.-J., Kim, J., Park, M. G., Yeom, Y. I., et al. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.6.811 · Cited by 32
Nagasue, N., Kohno, H., Chang, Y., et al. (1990) · Annals of Surgery · doi:10.1097/00000658-199008000-00006 · Cited by 30
Jonas, S., Bechstein, W. O., Heinze, T., et al. (1997) · Surgery · doi:10.1016/s0039-6060(97)90317-2 · Cited by 24
Pacchioni, D., Papotti, M. G., Andorno, E., et al. (1993) · Journal of Surgical Oncology · doi:10.1002/jso.2930530505 · Cited by 13
Cited by
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Toh, M. R., Wong, E. Y. T., Wong, S. H., Ng, A. W. T., Loo, L.-H., Chow, P. K.-H., & Ngeow, J. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.01.033 · Cited by 583
Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue
Dorak, M. T., & Karpuzoglu, E. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00268 · Cited by 493
Hsu, S.-K., Li, C.-Y., Lin, I.-L., Syue, W.-J., Chen, Y.-F., Cheng, K.-C., Teng, Y.-N., Lin, Y.-H., Yen, C.-H., & Chiu, C.-C. (2021) · Theranostics · doi:10.7150/thno.62521 · Cited by 484
The evolving epidemiology of hepatocellular carcinoma: a global perspective
Wallace, M. C., Preen, D., Jeffrey, G. P., & Adams, L. A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1028363 · Cited by 374
Metadata
- Authors
- Yeh, S.-H., & Chen, P.-J.
- Venue
- Oncology
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 78
- Issue
- Suppl. 1
- Pages
- 172-179
- ISSN
- 0030-2414 (ISSN-L)
- 1423-0232
- OpenAlex
- W2054789893
- Cited by
- 256
- References
- 69
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.